CA
NZ
UK
AU
IND
US
Key HighlightsThird quarter net loss was USD 208.4 million, or USD 0.26 per share, against USD 231.8 million, or USD 0.31, a year earlier, while the nine-month net loss was USD 613.5 million.Summit Therapeutics (NASDAQ:SMMT) closed a USD 2.0 billion grossEquityInvestmentfrom AstraZeneca on October …
Operating expenses were USD 21.9 million versus USD 16.6 million, with general and administrative expense of USD 10.8 million against USD 6.1 million. Management said the prior-year quarter benefited from a USD 2.5 million nonrecurring accrual reversal, and that excluding it, operating expenses rose …
Operating income was USD 76.7 million against a loss of USD 128.4 million, as cost of revenue fell to USD 649 million from USD 674 million and the company reported a grossMarginof 62%.Research and Developmentexpense rose to USD 478 million, and sales andMarketingexpense rose …
The company supplies electronics for commercial, off-highway and agricultural vehicles, including MirrorEye vision systems. Electronics segment sales rose 30.5% on higher North American commercial vehicle production, MirrorEye sales and MexicoManufacturingagreementRevenueafter the January 2026 sale of Control Devices. Brazil sales rose 25.3% on a new …
Gross margin was 70.9% against 82.2%, which included a 6.7 point lift from the shipment in the prior year. Excluding it, the prior-year margin would have been 75.5%. Management blamed higherManufacturingcosts from low second quarter output during an enterprise software rollout, higher freight, tariffs …
Healthcare revenue grew 9% to USD 1.1 billion, with service up 10%, consumables up 10% and capital equipment up 4%, whileOperating Incomewas USD 269.2 million versus USD 259.5 million. Applied Sterilization Technologies revenue rose 5% to USD 295.6 million, with a 21% decline in …
Gross margin was 52.2%, up from 45.9%, which management tied to the new NeuroStar strategy and better revenue cycle management at Greenbrook. Operating expenses fell 12.6% to USD 21.3 million, and income from operations was USD 5.0 million against a loss of USD 7.3 …
Hotel operating revenues fell USD 79.2 million, as hotel sales since July 1, 2025 removed USD 94.6 million, partly offset by USD 15.4 million from higher occupancy and rates. On a comparable basis for 87 hotels, occupancy was 71.8% against 68.6%, and average daily …
Cost of revenue fell 37% to USD 2.6 million, andGross Profitwas USD 13.7 million, down 6%. On our calculation, that is a grossMarginof about 84.0% against 77.9%.Research and Developmentspending fell 18% to USD 7.2 million, selling andMarketingeased 5% to USD 4.0 million, and general …
The chief executive said AI Services grew 28% and was the fastest-growing service line for the seventh quarter in a row. Excluding its largest client, year-over-year revenue growth was nearly 20% for the quarter, which implies that client weighed on the total, although the …
Please wait processing your request...